DATE: October 26, 2017
TIME: 12:00 PM PDT

This presentation will focus on recent advances in cellular therapy—from mesenchymal stromal cells (MSCs) to tumor-specific T-cells. More specifically, we will discuss how these cells are made in our academic good manufacturing practice (GMP) facility, how we try to meet the demands of our investigators and what challenges we must overcome to expand these therapies.

Who may this interest:

• Clinicians, researchers, laboratory technologists
• Cell therapy manufacturing professionals 
• Gene and immunotherapy manufacturing professionals

Learning Objective:
Identify challenges associated with early-stage cell therapy manufacturing and potential solutions